Mirae Asset Global Investments
HBIO icon

Mirae Asset Global Investments’s Harvard Bioscience HBIO Stock Holding History

Mirae Asset Global Investments’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,097
Closed -$112K – 2528
2023
Q4 		$112K Hold
2,097
– – ﹤0.01% 2442
2023
Q3 		$90.2K Hold
2,097
– – ﹤0.01% 2480
2023
Q2 		$115K Buy
+2,097
New +$115K ﹤0.01% 2473

Other funds holding HBIO

2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Mirae Asset Global Investments's HBIO Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Harvard Bioscience (HBIO) in Q1 2024, closing a stake of 2,097 shares — an estimated $112K sold.

Mirae Asset Global Investments first reported a position in HBIO in Q2 2023 and held it in 3 quarters. The position peaked at $115K in Q2 2023. 89 funds tracked by Wall St. Rank hold HBIO as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Harvard Bioscience position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 2,097 Harvard Bioscience shares in Q1 2024, an estimated $112K.
  • Mirae Asset Global Investments first reported a position in Harvard Bioscience in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's Harvard Bioscience position peaked at $115K in Q2 2023.
  • 89 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.